Enzyme activities were expressed as mmol substrate consumed per minute per mg protein or 106 cells. Gene expression Total RNA and protein was extracted form cells exposed to vehicle-control or paclitaxel at varying concentrations for 24 hours using the PARIS™ kit (Ambion, Austin, Texas, USA) according to manufacturer’s Capmatinib instructions. Total RNA was treated with TURBO DNA free (Ambion) to remove DNA contamination and the concentration was measured at 260 nm. The total RNA was reverse transcribed using random primers and the High Capacity
cDNA reverse transcription kit (Applied Biosystems) per the manufacturer’s product information. The human hypoxanthine phosphoribosyltransferase (HPRT) gene was selected as an endogenous control after assessing the gene expression of 11 potential controls using the TaqMan human endogenous control plate (Applied Biosystems). HPRT produced ΔCT values
that deviated little from zero, indicating relative to other candidate controls, that the expression of HPRT remains relatively consistent across the samples tested regardless of type of cells or treatment. Primers and probes for the dCK and CDA were from Applied Biosystems Assay on-Demand Gene expression products. The cDNA was amplified by quantitative real-time PCR in triplicate using the following thermal profile: an initial incubation at 50°C for 5 minutes, followed by 40 cycles of denaturation at 95°C for Edoxaban 15 seconds followed C646 price by annealing and extension at 60° for 1 minute with the Applied Biosystems 7900 HT sequence detection system. The quantitation of gene expression was AZD4547 ic50 performed relative to the calibrator (vehicle-control cells) using the ΔΔCT calculation for dCK and the relative standard curve calculation for CDA. A validation experiment
was performed that demonstrated the efficiencies were 0.08 for dCK and 1.1 for CDA. To use the ΔΔCT calculation, the efficiencies should be less than 0.1. Western blot Total protein was separated on a 12% SDS-polyacrylamide gel for dCK or a 14% SDS-polyacrylamide gel for CDA and transferred to a polyvinylidene diflouride (PVDF) membrane [25, 26]. The membrane was probed with the either dCK-pep antibody (obtained from Dr. Hatzis) at a 1:4,000 dilution or CDA antiserum (obtained from Dr. Momparler) at a 1:175 dilution followed by incubation with horseradish peroxidase-conjugated anti-rabbit IgG (Pierce, Rockford, Illinois, USA). The membrane was also probed with β-actin (Sigma-Aldrich Co) at 1:12,000 dilution, followed by incubation with horseradish peroxidase-conjugated anti-mouse IgG (Calbiochem, San Diego, California, USA) antibody as an endogenous control. Immuncomplexes were visualized by SuperSignal West Pico chemiluminescent substrate kit (Pierce, Rockford, IL) and the band density was semi-quantitated using ImageJ (v. 1.38×, http://rsb.info.nih.gov/ij/index.html) software.